Momentum Builds for Bipartisan CREATES Act

02-7-2019 Press Release

For Immediate Release Contact: Lauren Blair 201-213-5004 [email protected] Following the reintroduction of the bipartisan Creating and Restoring Equal Access To Equivalent Samples (CREATES) Act in the U.S. Senate and House of Representatives, CSRxP executive director, Lauren Aronson, praised the momentum and support for legislation to lower drug prices and increase competition: “We’re delighted to see the CREATES […]

CSRxP Statement On State Of The Union Address

02-6-2019 Press Release

For Immediate Release Contact: Lauren Blair 201-213-5004 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released the following statement in response to President Trump’s State of the Union address: “We appreciate President Trump’s commitment to making prescription drugs more affordable.  While pharmaceutical companies continue to rake in record profits, too many Americans […]

SOTU: It’s Time To Come Together To Tackle Drug Prices

02-5-2019 Press Release

Tonight, Americans from across the country will tune-in to listen to the President’s State of the Union address. As we prepare to hear the President’s remarks, there is one subject that is sure to be on everyone’s mind: out-of-control drug prices. With one-in-four Americans unable afford their prescription drugs, it’s no wonder lowering the price […]

CSRxP Leads Diverse Group Of Nearly 50 Organizations In Pledging Support For Bipartisan CREATES Act

02-5-2019 Press Release

Legislation Would Lower Prescription Drug Prices, Increase Competition, Prevent Manufacturers From “Gaming” Patent System   Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today led a group of nearly 50 organizations in sending a letter to U.S. Senators Chuck Grassley (R-IA), Patrick Leahy (D-VT), Amy Klobuchar (D-MN) and Mike Lee (R-UT) in support […]

CSRxP Statement on Trump Administration’s Latest Drug Pricing Proposal

02-1-2019 Press Release

For Immediate Release:  Contact: Lauren Blair (201) 213-5004 [email protected] The Campaign for Sustainable Rx Pricing (CSRxP) executive director, Lauren Aronson, issued the following statement in response to the Trump Administration’s latest proposed drug pricing rule: “We appreciate this administration’s continued work to tackle out-of-control drug prices.  It’s clear President Trump and U.S. Health and Human […]

RealClearHealth: Path Forward To Solving Out-Of-Control Drug Prices

01-31-2019 Press Release

Meaningful Reforms Have Already Taken Shape – Now It’s Up To Congress And President Trump To See Them Through Path Forward To Solving Out-Of-Control Drug Prices Lauren Aronson January 25, 2019 RealClearHealth   The millions of patients who are struggling to pay for prescription medication has reached epidemic proportions.  Drug prices are skyrocketing, while Big […]

Access To Drugs Is A Matter Of Life & Death, Mothers of Diabetic Children Testify Before Congress

01-30-2019 Press Release

At their first hearings of the 116th Congress, the Senate Finance and House Oversight and Reform Committees heard the heart-wrenching stories of two mothers whose diabetic children have suffered as a result of rising drug prices. Here are their stories: Kathy Sego, describing her son’s choice to ration his insulin after discovering the cost of […]

CSRxP Statement On House & Senate Committee Hearings On Skyrocketing Drug Prices

01-29-2019 Press Release

For Immediate Release: Contact: Lauren Blair (201) 213-5004 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) executive director, Lauren Aronson, today released the following statement after the U.S. House Oversight and Reform and U.S. Senate Finance Committees held their first hearings on drug pricing: “We appreciate the commitment of Senate Finance Committee […]

SHOT/CHASER: Pfizer & Novartis Double-Talk On Price Increases For Drugs Most Important To Bottom Lines

01-28-2019 Press Release

For Immediate Release: Contact: Lauren Blair (201) 213-5004 [email protected] SHOT: Pfizer & Novartis Introduce Minor Price Hikes On A Small Portion Of Their Drugs: Pfizer And Novartis Left The Prices To The “Vast Majority” Of Their Portfolios Unchanged. “Pharma giants Pfizer and Novartis have officially raised prices on dozens of drugs, according to data from […]

CSRxP Applauds CMS’s Commitment To Lower Drug Prices

01-25-2019 Press Release

Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today sent a letter to the Centers for Medicare and Medicaid Services (CMS) Administrator Seema Verma applauding policies in the proposed rule, “Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses.” In the letter, CSRxP wrote: “Given the drug pricing […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.